NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 32 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2021. The put-call ratio across all filers is 1.77 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $3,000 | -25.0% | 1,912 | 0.0% | 0.00% | – |
Q1 2021 | $4,000 | 0.0% | 1,912 | 0.0% | 0.00% | – |
Q4 2020 | $4,000 | -20.0% | 1,912 | 0.0% | 0.00% | – |
Q3 2020 | $5,000 | -37.5% | 1,912 | 0.0% | 0.00% | – |
Q2 2020 | $8,000 | +700.0% | 1,912 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 1,912 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | +100.0% | 1,912 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 1,912 | -6.2% | 0.00% | – |
Q2 2019 | $1,000 | – | 2,039 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Allred Capital Management, LLC | 65,303 | $176,000 | 0.11% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,540 | $358,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 51,648 | $139,000 | 0.00% |
PATHSTONE FAMILY OFFICE, LLC | 10,050 | $28,000 | 0.00% |
LifePlan Financial Group, Inc | 1,440 | $4,000 | 0.00% |
Sowell Financial Services LLC | 11,234 | $30,000 | 0.00% |
Jacobi Capital Management LLC | 1,000 | $3,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 65,089 | $176,000 | 0.00% |
Sound Income Strategies, LLC | 599 | $2,000 | 0.00% |
UBS Group AG | 1,785 | $5,000 | 0.00% |